“Japan’s Pharmaceutical Industry Gains Momentum with $1.1 Billion Shionogi-Torii Deal Amid Rising Sector Activity”

Japan continues to see notable activity in the pharmaceutical sector, with Shionogi & Co Ltd. offering $1.1 billion to acquire Tokyo-listed Torii Pharmaceutical and other assets from Japan Tobacco. Significant legal representation has been mobilized, with Nagashima Ohno & Tsunematsu advising Torii, Nishimura & Asahi acting for Shionogi, and Mori Hamada representing Japan Tobacco. Earlier this year, deals such as Bain Capital’s purchase of Mitsubishi Tanabe Pharma for $3.5 billion and Blackstone’s acquisition of a majority stake in CMIC Holdings underscore the growing momentum in the sector. For more details, refer to the original article here.